|
"Mechanisms of Damage-Induced Homologous Recombination"
|
5R01CA079827-06
|
$279,125
|
$279,125
|
ENGELWARD, BEVIN
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
"Using Perceptual Mapping to Develop Low Literacy CRC Screening Decision Aids"
|
5R21CA120122-02
|
$180,000
|
$180,000
|
GORDON, THOMAS
|
TEMPLE UNIVERSITY
|
|
15-PGDH, A Novel in Vivo Suppressor of Colon Neoplasia in Mouse and Man
|
5R01CA127306-02
|
$398,846
|
$398,846
|
MARKOWITZ, SANFORD
|
CASE WESTERN RESERVE UNIVERSITY
|
|
31st NATIONAL MEDICINAL CHEMISTRY SYMPOSIUM
|
1R13CA134005-01
|
$9,000
|
$900
|
GOLD, BARRY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
3D Massive Training ANN for CAD for Colon Cancer in CT Colonography
|
5R01CA120549-02
|
$291,650
|
$291,650
|
SUZUKI, KENJI
|
UNIVERSITY OF CHICAGO
|
|
402 - RFP: N43-CM-87007-68 TOPIC 251: DEVELOPMENT OF ANTICANCER AGENTS REQUEST
|
N43CM800026-000
|
$149,558
|
$149,558
|
CASTOR, TREVOR
|
APHIOS CORP:1105999
|
|
5-A-DAY CUSTOMIZED SURVEY STUDY - TASK ORDER NO. 2
|
N02PC513009-003
|
|
$0
|
HURWITZ, PAUL
|
WESTAT:1109753
|
|
5-LOX-1 and Clinical Chemoprevention of Colon Tumors
|
5R01CA106577-04
|
$437,535
|
$437,535
|
SHUREIQI, IMAD
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
A Cellular and Molecular Analysis of the Intravasation Step in Tumor Metastasis
|
1R01CA129484-01A1
|
$393,213
|
$196,607
|
QUIGLEY, JAMES
|
SCRIPPS RESEARCH INSTITUTE
|
|
A cellular key to the gastric inflammation-metaplasia-carcinoma sequence?
|
5R21CA124589-02
|
$210,720
|
$210,720
|
GUMUCIO, DEBORAH
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
A flexible somatic and sporadic mouse model for liver cancers
|
1R21CA131625-01A1
|
$168,905
|
$168,905
|
CHEN, XIN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
A genomic scan of hereditary prostate cancer families with an occurrence of colon
|
1R03CA133938-01
|
$88,000
|
$88,000
|
STANFORD, JANET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
A Lectin Glycoarray Approach for Markers of Pancreatic Cancer
|
5R21CA124441-02
|
$182,400
|
$182,400
|
LUBMAN, DAVID
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
A Mediterranean Diet in for Colon Cancer Prevention
|
5R01CA120381-02
|
$367,050
|
$367,050
|
DJURIC, ZORA
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
A Mitogen-induced G Protein-coupled Receptor
|
Z01 SC 009389
|
$68,486
|
$6,849
|
Kelly, Kathleen
|
CCR (NCI)
|
|
A Mouse Model for Human Gastrointestinal Stromal Tumor
|
5R01CA102774-05
|
$354,934
|
$354,934
|
BESMER, PETER
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
A mouse model for p120 downregulation in cancer
|
5R01CA111947-04
|
$287,369
|
$201,158
|
REYNOLDS, ALBERT
|
VANDERBILT UNIVERSITY
|
|
A mouse model of the zebrafish meltdown mutant
|
5R21CA120491-02
|
$157,500
|
$157,500
|
PACK, MICHAEL
|
UNIVERSITY OF PENNSYLVANIA
|
|
A Multi-State Study of Cancer Treatment and Outcomes Among American Indians
|
5R01CA125231-02
|
$426,676
|
$102,402
|
RAMSEY, SCOTT
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
A New Radiotracer for Sentinel Node Mapping of Colon Cancer
|
5R21CA126037-02
|
$185,400
|
$185,400
|
HOH, CARL
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
A Novel Biotherapeutic Treatment for Pancreatic Cancer
|
1R43CA117283-01A2
|
$99,965
|
$99,965
|
Xu, Kevin
|
BEXION PHARMACEUTICALS, INC.
|
|
A Novel Modifier Locus Suppressing ApcMin Intestinal Polyposis
|
1F31CA134181-01
|
$37,435
|
$37,435
|
NNADI, STEPHANIE
|
THOMAS JEFFERSON UNIVERSITY
|
|
A Novel Non-Invasive CRC Test Based on Mass Spec Of In Vitro Expressed Proteins
|
5R44CA119565-03
|
$455,651
|
$455,651
|
Han, James
|
AMBERGEN, INC
|
|
A novel sulindac derivative for colon cancer chemoprevention
|
5R03CA128021-02
|
$110,049
|
$110,049
|
PIAZZA, GARY
|
SOUTHERN RESEARCH INSTITUTE
|
|
A Physician-Based Trial to Increase Colorectal Cancer Screening in Chinese
|
5R01CA121023-02
|
$538,717
|
$538,717
|
LIANG, WENCHI
|
GEORGETOWN UNIVERSITY
|
|
A PILOT INVESTIGATION OF ETHNIC DISPARITIES IN PATIENT-INITIATED PREMATURE TREATM
|
5R03CA128470-02
|
$72,000
|
$72,000
|
Adams, Swann
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
|
A Population Based Policy Model for Colorectal Cancer
|
5U01CA088204-08
|
$189,755
|
$189,755
|
KUNTZ, KAREN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
A Population-Based Analysis of Care and Outcomes for Hepatocellular Carcinoma
|
1F32CA136135-01
|
$54,746
|
$54,746
|
Massarweh, Nader
|
UNIVERSITY OF WASHINGTON
|
|
A Prospective Study of Colorectal Cancer: One-Carbon Metabolism and Inflammation
|
1R01CA120523-01A2
|
$641,822
|
$641,822
|
ULRICH, CORNELIA
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
A Randomized Trial of Hep B Screening and Vaccination in High Risk Vietnamese
|
5R01CA129763-02
|
$479,743
|
$479,743
|
MA, GRACE
|
TEMPLE UNIVERSITY
|
|
A Risk Prediction Model for Colorectal Cancer Screening
|
1R01CA131197-01A1
|
$389,327
|
$389,327
|
SCHROY, PAUL
|
BOSTON MEDICAL CENTER
|
|
A Standards-based Tool for Clinical Trials Protocol Authoring
|
5R21CA127507-02
|
$118,800
|
$39,204
|
EL SAADAWI, GILAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
A Sustainable Approach to Increasing Cancer Screening in Community Health Centers
|
5R01CA126596-02
|
$592,024
|
$148,006
|
EMMONS, KAREN
|
DANA-FARBER CANCER INSTITUTE
|
|
A Tumor Suppressor Function for the c-Fes Tyrosine Kinase in Colon Cancer
|
1R01CA123756-01A2
|
$270,516
|
$270,516
|
SMITHGALL, THOMAS
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
A web-based tailored health behavior intervention for African American colon canc
|
1R03CA138118-01
|
$73,792
|
$73,792
|
SATIA, JESSIE
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
AACR-TREC-NIH Think Tank Conference: Energy Balance and Cancer; Mechanisms and Me
|
1R13CA134016-01
|
$10,000
|
$4,000
|
Berger, Nathan
|
CASE WESTERN RESERVE UNIVERSITY
|
|
AARP prospective study of diet and cancer
|
Z01 CP010196-03152
|
$2,416,410
|
$120,820
|
Schatzkin, Arthur
|
DCEG (NCI)
|
|
ABC Transporters in Human Disease and Multidrug Resistance
|
Z01 BC 005725
|
$579,181
|
$115,836
|
Dean, Michael
|
CCR (NCI)
|
|
Aberrant Crypt Foci as a Biomarker for Chemoprevention
|
5R01CA113681-03
|
$1
|
$1
|
SINICROPE, FRANK
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
ACOSOG Central Specimen Bank
|
5U24CA114736-04
|
$340,041
|
$102,012
|
OTA, DAVID
|
DUKE UNIVERSITY
|
|
ACOSOG Competing Renewal
|
2U10CA076001-12
|
$3,011,166
|
$180,670
|
OTA, DAVID
|
DUKE UNIVERSITY
|
|
ACOSOG Competing Renewal
|
3U10CA076001-12S1
|
$342,900
|
$20,574
|
OTA, DAVID
|
DUKE UNIVERSITY
|
|
Acoustic Radiation Force Imaging of Colorectal Tissues
|
5R01CA114075-04
|
$280,299
|
$140,150
|
NIGHTINGALE, KATHRYN
|
DUKE UNIVERSITY
|
|
Activity & resistance of Gleevec in GI stromal tumors
|
5K23CA109060-05
|
$136,080
|
$136,080
|
TRENT, JONATHAN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Adduct Induced Frameshift Mutagenesis
|
5R01CA055678-17
|
$238,029
|
$238,029
|
Stone, Michael
|
VANDERBILT UNIVERSITY
|
|
Adenocarcinoma of the Lung: role of NNK susceptibility
|
5R01CA055769-18
|
$582,839
|
$145,710
|
SPITZ, MARGARET
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Adenoviral GFP targeting of metastatic human tumors using multiple delivery route
|
1R43CA132242-01
|
$149,575
|
$149,575
|
Kishimoto, Hiroyuki
|
ANTICANCER, INC.
|
|
Adherence and the Economics of Colon Cancer Screening
|
5R01CA106773-03
|
$271,278
|
$271,278
|
INADOMI, JOHN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Adhesive Regulation During Cell Migration
|
5R01CA085862-09
|
$272,687
|
$109,075
|
HUTTENLOCHER, ANNA
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Adoptive Cell Transfer Immunotherapy of Cancer
|
Z01 BC 010984
|
$1,116,265
|
$78,139
|
Rosenberg, Steven
|
CCR (NCI)
|
Total relevant funding to Digestive Diseases for this search: $439,873,191
|